Literature DB >> 10483016

Disease expression and class II HLA antigens in systemic lupus erythematosus.

D D Gladman1, M B Urowitz, G A Darlington.   

Abstract

The aim of this investigation was to examine the relationship between Class II HLA antigens and disease expression in systemic lupus erythematosus (SLE). HLA-DR and DQ antigen frequency was studied serologically in 217 SLE patients followed prospectively and compared to 320 healthy controls. The relationship between HLA antigens and the presence of disease manifestations, as well as death was investigated in 117 SLE patients enrolled within the first year of their disease. A univariate analysis confirmed the association between HLA-DR3 and SLE. HLA antigen DR1, DR6, DR7, DQw1 and DQw3 were decreased in patient group compared to the controls. A logistic regression model showed a significantly negative association with HLA-DR1, DR6 and DR7, and a positive association with HLA-DR3. The reduced frequency of HLA-DQw1 and DQw3 was maintained using a logistic procedure. Cox Proportional Hazards models revealed no association between HLA-Class II antigens and death. Logistic regression models revealed no associations between central nervous system (CNS) disease nor musculoskeletal manifestations with any of the DR antigens. There was a trend towards a lower frequency of HLA-DR6 in patients with renal involvement and lower prevalence of HLA-DR1 and HLA-DR7 in patients with vasculitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483016     DOI: 10.1177/096120339900800610

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus.

Authors:  Vaidehi R Chowdhary; Chao Dai; Ashenafi Y Tilahun; Julie A Hanson; Michele K Smart; Joseph P Grande; Govindarajan Rajagopalan; Shu-Man Fu; Chella S David
Journal:  J Immunol       Date:  2015-10-16       Impact factor: 5.422

2.  HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population.

Authors:  Markéta Fojtíková; Peter Novota; Pavlína Cejková; Satu Pešičková; Dana Tegzová; Marie Cerná
Journal:  Rheumatol Int       Date:  2010-03-30       Impact factor: 2.631

3.  HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.

Authors:  Umesh S Deshmukh; Davis L Sim; Chao Dai; Carol J Kannapell; Felicia Gaskin; Govindarajan Rajagopalan; Chella S David; Shu Man Fu
Journal:  J Autoimmun       Date:  2011-08-24       Impact factor: 7.094

4.  MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.

Authors:  N J McHugh; P Owen; B Cox; J Dunphy; K Welsh
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

5.  HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus.

Authors:  Antoni Hrycek; Urszula Siekiera; Paweł Cieślik; Witold Szkróbka
Journal:  Rheumatol Int       Date:  2004-09-21       Impact factor: 2.631

6.  Identification of two independent risk factors for lupus within the MHC in United Kingdom families.

Authors:  Michelle M A Fernando; Christine R Stevens; Pardis C Sabeti; Emily C Walsh; Alasdair J M McWhinnie; Anila Shah; Todd Green; John D Rioux; Timothy J Vyse
Journal:  PLoS Genet       Date:  2007-11       Impact factor: 5.917

7.  The involvement of HLA -DRB1*, DQA1*, DQB1* and complement C4A loci in diagnosing systemic lupus erythematosus among Tunisians.

Authors:  Khaled Ayed; Yousr Gorgi; Saloua Ayed-Jendoubi; Rafika Bardi
Journal:  Ann Saudi Med       Date:  2004 Jan-Feb       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.